Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
It is currently not allowed for patients with prolonged aplasia, following intensive chemotherapy, to brush teeth due to the risk of damaging the oral mucosa with risk of haemorrhage and infectious entrance door. Mouthwash is currently prescribed to prevent these complications. Many patients, however, ask to brush their teeth for greater comfort and a feeling of well-being.
Some haematology services allow tooth brushing while others prohibit tooth brushing without study.
Investigators wanted to conduct a study to assess the feasibility, the safety of tooth brushing for aplastic patient comfort, hemopathy and/or chemotherapies causing mucous membrane alteration that increases infectious risk and the risk of gingivorragia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Tooth brushing | Experimental |
| |
| Mouthwash | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Toothbrush | Device | Brushing teeth three times a day (extra-soft toothbrush) with a 1.4% baking mouthwash solution. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Highest score obtained at the OAG (Oral Assessment Guide) scale during the observation period | Assess the effect of the "teeth brushing" versus "mouth bath" strategy on the oral condition of patients hospitalized in the protected area of the Blood Disease Service with predictable prolonged aplasia and risk of mucite | 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Number of septicemia | Estimate the effect of the strategy in terms of Infectious risks | 1 month |
| Incidence of intra-oral hemorrhage | Estimate the effect of the strategy in terms of Hemorrhagic risk |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Angers | Angers | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009067 | Mouthwashes |
| ID | Term |
|---|---|
| D001697 | Biomedical and Dental Materials |
| D020313 | Specialty Uses of Chemicals |
| D020164 | Chemical Actions and Uses |
| D003358 | Cosmetics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Mouthwashes | Drug | Mouthwashes three times a day with a 1.4% baking mouthwash solution. |
|
| 1 month |
| Number of days with intra-oral hemorrhage | Estimate the effect of the strategy in terms of Hemorrhagic risk | 1 month |
| Number of days with fever | Estimate the effect of the strategy in terms of Infectious risks | 1 month |
| Incidence of bacterial infections during hospitalization | Estimate the effect of the strategy in terms of Infectious risks | 1 month |
| Incidence of fungal infections during hospitalization | Estimate the effect of the strategy in terms of appearance of mucite | 1 month |
| Percentage of patients receiving morphinics during hospitalization | Estimate the effect of the strategy in terms of pain | 1 month |
| Number of days with morphinic treatment | Estimate the effect of the strategy in terms of pain | 1 month |
| Percentage of patients receiving parenteral nutrition during hospitalization | Estimate the effect of the strategy in terms of patient's tolerance to oral care | 1 month |
| Number of days with parenteral nutrition | Estimate the effect of the strategy in terms of patient's tolerance to oral care | 1 month |
| Percentage of patients who had to discontinue treatment on medical advice | Estimate the effect of the strategy in terms of patient's tolerance to oral care | 1 month |
| D008420 | Manufactured Materials |
| D013676 | Technology, Industry, and Agriculture |